As regulatory bodies like the FDA continue to update drug labeling with biomarkers, the role of high-precision medical devices will only grow
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
As regulatory bodies like the FDA continue to update drug labeling with biomarkers, the role of high-precision medical devices will only grow
CE Marking and ARCH clinical trial data position the Liverty™ TIPS Stent Graft to expand treatment options for patients with advanced liver disease
Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial availability anticipated in mid-2026. The announcement marks the planned reintroduction of the minimally invasive technology to clinicians and patients following a period of limited market availability. The Ellipsys System, previously available...
The study's PI is Michael Lo, M.D., a leading plastic surgeon at Cabrini Health
Mechanical Thrombectomy Dramatically Outperforms Standard PE Care at 90 Days
On March 12, 2026, the first implant of the ProStyle M® Transcatheter Mitral Valve System (ProStyle M®) was successfully completed under pure ultrasound guidance as part of its confirmatory clinical study. The device is independently developed by KingstronBio Technology (Changshu) Co., Ltd. (KingstronBio). The procedure was performed by Professor Wang Chunsheng and Professor...
As the pace of biotechnology research accelerates, companies are increasingly challenged to balance rapid innovation with the protection of sensitive genetic information.
Variational AI introduces Enki™ 4: an improved algorithm and architecture designed to scale, expanding the pre-trained target coverage from 592 to 760 and now applicable to proximity-based therapeutics and novel payloads for antibody drug conjugates
Akira Kitamura, GM, AI Drug Development Division of NEC Corporation and CEO of NEC Bio, added, "This agreement is an important milestone in our partnership with Transgene and reflects NEC’s long-term commitment to the development of TG4050
Aidoc’s $150M funding will enhance clinical AI solutions, impacting 100 million patients’ care and decision-making processes.

By cooling the scalp before, during, and after chemotherapy, Amma™ reduces blood flow to hair follicles, shielding them from chemotherapy drugs and therefore preventing hair loss. Amma™ offers a continuous cooling system that eliminates the need for dry ice or frequent cap changes, making it a more accessible alternative to traditional methods.

While virtual reality in telehealth might seem like a novel technology to incorporate into healthcare, at least one portion of our field has been using it for 250 years. Simulation technology has long been instrumental in medical training since it makes failure safe while students practice key skills.

According to recent research, 15% of the global population over the age of 30 is affected by osteoarthritis, or OA, the most common form of arthritis. This same study projects that OA will affect nearly 1 billion people by the year 2050. These statistics show that OA is a pressing medical concern that should be a top priority for medical professionals seeking to improve their patients’ quality of life.

Published in the journal Heliyon, the new study found that SING IMT improved both distance and near vision — while exhibiting minimal effects on corneal endothelial cell density and a favorable safety profile.
The ADAPT study will evaluate the safety and effectiveness of the company’s Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System
This expansion of indications now includes use as a bone void filler for the treatment of tumors, cysts, trauma, and osteomyelitis. This landmark clearance represents a significant advancement in the capabilities of SurGenTec®’s cutting-edge technology and highlights the company’s commitment to enhancing patient care in orthopedic and spine surgery.
In his role, Danny Marshall will focus on scaling patient-first product innovation and Inventus’ global platform

Sam Ricchezza is the latest addition to an executive team tasked with continuing the CMO’s recent growth trends.
Appointment highlights Cardiosense’s growth trajectory following FDA clearance, clinical milestones, and expanded leadership team

“This program is saving lives, reducing disability, and changing the futures of stroke patients,” said Dr. Dmytro Lebedynets, a neurologist at Feofaniya Clinical Hospital and consultant on stroke to the World Bank and the Ministry of Health of Ukraine. “With these advanced tools, we can deliver timely and precise life-saving care, even in emergencies. It’s a game-changer for our patients. Now all the regions of our country will be able to provide the full spectrum of care to stroke patients.”

“The collaboration between Philips and AWS gives healthcare providers scalable, secure-by-design cloud-enabled solutions to accelerate healthcare innovation,” said Matt Garman, CEO of AWS. “Combining Philips’ healthcare informatics portfolio with AWS generative AI capabilities gives clinicians access to imaging insights so they can deliver more effective and efficient care to patients anywhere, anytime, with best-in-class security and privacy.”
“This latest expansion of coverage by Noridian means that even more patients could be positively impacted by PlaqueIQ, which offers the only non-invasive measurement of lipid-rich necrotic core, a vulnerable, high-risk component of plaque that can lead to heart attack and stroke,”4 said Kelly Huang, CEO of Elucid. “These recent decisions from five of the seven MACs recognize the importance of new technologies like ours that can help quantify and classify coronary artery plaque to help physicians reduce the clinical and economic burden of cardiovascular disease.”

Trust is now the most valuable asset in healthcare digital marketing

In medicine, material science, or environmental research, chemicals are the building blocks of significant progress

If you’ve ever watched a medical device rep dart between hospitals, you know the job isn’t just about pitching a product. They’re up before sunrise,

In the competitive field of medical technology, the business of launching a new device is multifaceted
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.